Multisystem Inflammatory Syndrome in an Adolescent Following SARS-CoV-2 Exposure Despite Three Doses of a COVID-19 Vaccine.
R I Med J (2013)
; 105(5): 41-45, 2022 Jun 01.
Article
in English
| MEDLINE | ID: covidwho-1863925
ABSTRACT
The multisystem inflammatory syndrome in children (MIS-C) is a known complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the pediatric population. Recent studies have demonstrated high efficacy of a two-dose vaccine series in preventing MIS-C among adolescents. To date, such studies have only included children exposed to SARS-CoV-2 prior to the emergence of the Omicron variant (B.1.1.529). We report a case of an adolescent who received three doses of a vaccine yet developed MIS-C following known exposure to SARS-CoV-2. Given the uncertainty in whether current vaccines offer as much protection against MIS-C due to the Omicron variant or any potential new variants as they have for older variants, pediatric providers should maintain a high index of suspicion for MIS-C regardless of vaccination status.
Keywords
Search on Google
Collection:
International databases
Database:
MEDLINE
Main subject:
Systemic Inflammatory Response Syndrome
/
Connective Tissue Diseases
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Observational study
Topics:
Long Covid
/
Vaccines
/
Variants
Limits:
Adolescent
/
Humans
Language:
English
Journal:
R I Med J (2013)
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS